Ligand validation:4UDK

BMA: beta-D-mannopyranose

BMA is a Ligand Of Interest in 4UDK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UDK_BMA_E_329	4%	8%	0.344	0.722	1.04	3.72	1	9	1	0	100%	0.6
4UDK_BMA_C_329	4%	6%	0.37	0.736	1.46	3.72	1	9	5	0	100%	0.6
4UDK_BMA_B_329	3%	13%	0.326	0.645	1.15	2.92	1	9	2	0	100%	1
4UDK_BMA_A_329	2%	5%	0.36	0.668	1.4	4.01	1	8	6	0	100%	0.6
4UDK_BMA_D_329	2%	7%	0.377	0.643	1.28	3.77	1	8	3	0	100%	0.6
4UDK_BMA_F_329	2%	11%	0.385	0.647	1.09	3.27	1	9	5	0	100%	0.6
4UDJ_BMA_C_329	69%	19%	0.139	0.953	1.36	2.23	1	6	1	0	100%	1
5IDB_BMA_A_1003	100%	57%	0.048	0.995	0.68	0.94	-	1	0	0	100%	1
2GUD_BMA_A_123	96%	59%	0.07	0.981	0.56	0.97	-	-	0	0	100%	0.25
5A7V_BMA_A_1385	95%	46%	0.07	0.976	0.76	1.34	1	3	0	0	100%	0.5
4CD4_BMA_A_1422	95%	68%	0.07	0.988	0.52	0.69	-	-	0	0	92%	0.9167
6Q4Y_BMA_A_401	93%	57%	0.071	0.967	0.46	1.17	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.